Menu

FDA warns of rare ‘eye stroke’ risk from GLP-1 drugs
📰

FDA warns of rare ‘eye stroke’ risk from GLP-1 drugs

The Hill News·Nathaniel Weixel·6 days ago
#M6HR45ZS
#thehill#condition#food#drug#administration
Reading 0:00
15s threshold

The Food and Drug Administration (FDA) ‌on Monday required pharmaceutical companies to warn patients and healthcare providers of a potential increased risk of a serious eye condition associated with the use of GLP-1 drugs for weight loss and diabetes.  Non-arteritic anterior ischemic optic neuropathy (NAION), often referred to as an “eye stroke,” is a rare condition…